American Century Companies’s Agios Pharmaceuticals AGIO Stock Holding History

American Century Companies's AGIO Position: Q2 2026 in Review

American Century Companies increased its Agios Pharmaceuticals (AGIO) stake by 12% in Q2 2026, buying an estimated $433K and bringing the position to 134,512 shares worth $4.99M. The position accounts for ﹤0.01% of the portfolio, ranked #1884.

American Century Companies first reported a position in AGIO in Q3 2014 and has held it in 26 quarters since. The position peaked at $19.4M in Q2 2015. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

• American Century Companies held 134,512 shares of Agios Pharmaceuticals worth $4.99M as of Q2 2026.
• American Century Companies bought 14,259 Agios Pharmaceuticals shares in Q2 2026, an estimated $433K.
• Agios Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #1884 holding.
• American Century Companies first reported a position in Agios Pharmaceuticals in Q3 2014 and has held it in 26 quarters since.
• American Century Companies's Agios Pharmaceuticals position peaked at $19.4M in Q2 2015.
• 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.